{
    "General": {
        "Code": "UR9A",
        "Type": "Common Stock",
        "Name": "CLINUVEL PHARMAC.ADRS1",
        "Exchange": "F",
        "CurrencyCode": "EUR",
        "CurrencyName": "Euro",
        "CurrencySymbol": "\u20ac",
        "CountryName": "Germany",
        "CountryISO": "DE",
        "OpenFigi": null,
        "ISIN": "US1887691038",
        "LEI": "5299004VJH3VCYLK6519",
        "PrimaryTicker": null,
        "CIK": null,
        "EmployerIdNumber": null,
        "FiscalYearEnd": "June",
        "IPODate": null,
        "InternationalDomestic": null,
        "Sector": "Healthcare",
        "Industry": "Biotechnology",
        "GicSector": "Health Care",
        "GicGroup": "Pharmaceuticals, Biotechnology & Life Sciences",
        "GicIndustry": "Biotechnology",
        "GicSubIndustry": "Biotechnology",
        "Description": "Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), which provoke prolonged cellular activity; and PR\u00c9NUMBRA, a liquid injectable formulation of afamelanotide. Clinuvel Pharmaceuticals Limited has a collaboration agreement with HK Winhealth Pharma Group Co. Limited t to treat EPP patients with SCENESSE under a named patient program in the People's Republic of China. The company was founded in 1987 and is headquartered in Melbourne, Australia.",
        "Address": null,
        "AddressData": null,
        "Listings": {},
        "Officers": {},
        "Phone": null,
        "WebURL": null,
        "LogoURL": "",
        "FullTimeEmployees": 0,
        "UpdatedAt": "2023-09-01"
    },
    "Highlights": {
        "MarketCapitalization": 537146432,
        "MarketCapitalizationMln": 537.1464,
        "EBITDA": 44523576,
        "PERatio": 30.5714,
        "PEGRatio": null,
        "WallStreetTargetPrice": null,
        "BookValue": 3.332,
        "DividendShare": 0.05,
        "DividendYield": 0.0023,
        "EarningsShare": 0.35,
        "EPSEstimateCurrentYear": 0,
        "EPSEstimateNextYear": 0,
        "EPSEstimateNextQuarter": 0,
        "EPSEstimateCurrentQuarter": 0,
        "MostRecentQuarter": "2023-06-30",
        "ProfitMargin": 0.3908,
        "OperatingMarginTTM": 0.5634,
        "ReturnOnAssetsTTM": 0.1633,
        "ReturnOnEquityTTM": 0.2109,
        "RevenueTTM": 78321320,
        "RevenuePerShareTTM": 1.585,
        "QuarterlyRevenueGrowthYOY": 0.192,
        "GrossProfitTTM": 70800253,
        "DilutedEpsTTM": 0.35,
        "QuarterlyEarningsGrowthYOY": 0.287
    },
    "Valuation": {
        "TrailingPE": 30.5714,
        "ForwardPE": 0,
        "PriceSalesTTM": 0,
        "PriceBookMRQ": 0,
        "EnterpriseValue": 422287296,
        "EnterpriseValueRevenue": 0,
        "EnterpriseValueEbitda": 0
    },
    "SharesStats": {
        "SharesOutstanding": 49410300,
        "SharesFloat": 37131375,
        "PercentInsiders": 0,
        "PercentInstitutions": 0.009000000000000001,
        "SharesShort": null,
        "SharesShortPriorMonth": null,
        "ShortRatio": null,
        "ShortPercentOutstanding": null,
        "ShortPercentFloat": null
    },
    "Technicals": {
        "Beta": 0.8255,
        "52WeekHigh": 18,
        "52WeekLow": 10,
        "50DayMA": 11.046,
        "200DayMA": 12.4595,
        "SharesShort": 0,
        "SharesShortPriorMonth": 0,
        "ShortRatio": 0,
        "ShortPercent": 0
    },
    "SplitsDividends": {
        "ForwardAnnualDividendRate": 0.03,
        "ForwardAnnualDividendYield": 0.0023,
        "PayoutRatio": 0.062,
        "DividendDate": null,
        "ExDividendDate": "2022-09-09",
        "LastSplitFactor": null,
        "LastSplitDate": null,
        "NumberDividendsByYear": {
            "0": {
                "Year": 2020,
                "Count": 1
            },
            "1": {
                "Year": 2021,
                "Count": 1
            },
            "2": {
                "Year": 2022,
                "Count": 1
            }
        }
    },
    "Holders": null,
    "InsiderTransactions": {},
    "outstandingShares": {
        "annual": {},
        "quarterly": {}
    },
    "Earnings": {
        "History": {},
        "Trend": {},
        "Annual": {}
    },
    "Financials": {
        "Balance_Sheet": {
            "currency_symbol": null,
            "quarterly": {},
            "yearly": {}
        },
        "Cash_Flow": {
            "currency_symbol": null,
            "quarterly": {},
            "yearly": {}
        },
        "Income_Statement": {
            "currency_symbol": null,
            "quarterly": {},
            "yearly": {}
        }
    }
}